Literature DB >> 28620798

"Inflammatory skin march" in atopic dermatitis and psoriasis.

Masutaka Furue1, Takafumi Kadono2.   

Abstract

BACKGROUND: Comorbidities of cardiovascular diseases (CVDs), metabolic syndrome and autoimmune diseases with systemic inflammation are recent topics in medicine. Inflammatory skin diseases such as atopic dermatitis and psoriasis are an active source of diverse proinflammatory cytokines and chemokines, which are readily detectable in the circulation and are likely to be involved in developing comorbidities. EVIDENCE: Both atopic dermatitis and psoriasis are frequently comorbid with CVD, metabolic syndrome and autoimmune diseases, the consequence of which is called "inflammatory skin march", "psoriatic march" or "march of psoriasis".
CONCLUSION: In this review, we summarize the epidemiological evidence and pathogenetic concepts regarding inflammatory skin march in atopic dermatitis and psoriasis.

Entities:  

Keywords:  Atopic dermatitis; Comorbidity; Proinflammatory cytokines; Psoriasis; Systemic inflammation

Mesh:

Substances:

Year:  2017        PMID: 28620798     DOI: 10.1007/s00011-017-1065-z

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  142 in total

Review 1.  Systemic immune mechanisms in atopic dermatitis and psoriasis with implications for treatment.

Authors:  Emma Guttman-Yassky; James G Krueger; Mark G Lebwohl
Journal:  Exp Dermatol       Date:  2017-05-09       Impact factor: 3.960

2.  The role of T-cell reactivity towards the autoantigen α-NAC in atopic dermatitis.

Authors:  A Heratizadeh; I Mittermann; H Balaji; K Wichmann; M Niebuhr; R Valenta; T Werfel
Journal:  Br J Dermatol       Date:  2011-02       Impact factor: 9.302

3.  Bullous pemphigoid associated with psoriasis: A possible example of an inverse intramolecular epitope-spreading phenomenon.

Authors:  Kazunori Okahashi; Naoki Oiso; Norito Ishii; Shusuke Uchida; Hiromasa Matsuda; Takashi Hashimoto; Akira Kawada
Journal:  J Dermatol       Date:  2015-04-22       Impact factor: 4.005

4.  Autoimmune diseases in adults with atopic dermatitis.

Authors:  Yuki M F Andersen; Alexander Egeberg; Gunnar H Gislason; Lone Skov; Jacob P Thyssen
Journal:  J Am Acad Dermatol       Date:  2016-10-11       Impact factor: 11.527

5.  Case of subepidermal autoimmune bullous disease with psoriasis vulgaris reacting to both BP180 C-terminal domain and laminin gamma-1.

Authors:  Syuichi Ishida; Kazuo Takahashi; Miwa Kanaoka; Tomoko Okawa; Chiharu Tateishi; Atsushi Yasukochi; Norito Ishii; Xiaoguang Li; Takashi Hashimoto; Michiko Aihara
Journal:  J Dermatol       Date:  2015-02-14       Impact factor: 4.005

6.  Adalimumab treatment optimization for psoriasis: Results of a long-term phase 2/3 Japanese study.

Authors:  Akihiko Asahina; Mamitaro Ohtsuki; Takafumi Etoh; Yihua Gu; Martin M Okun; Henrique D Teixeira; Yuji Yamaguchi; Hidemi Nakagawa
Journal:  J Dermatol       Date:  2015-06-29       Impact factor: 4.005

7.  Assessments of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in Korean patients with psoriasis vulgaris and psoriatic arthritis.

Authors:  Dae Suk Kim; Dongyun Shin; Min Seok Lee; Hee Ju Kim; Do Young Kim; Soo Min Kim; Min-Geol Lee
Journal:  J Dermatol       Date:  2015-08-18       Impact factor: 4.005

8.  IL-17 drives psoriatic inflammation via distinct, target cell-specific mechanisms.

Authors:  Hye-Lin Ha; Hongshan Wang; Prapaporn Pisitkun; Jin-Chul Kim; Ilaria Tassi; Wanhu Tang; Maria I Morasso; Mark C Udey; Ulrich Siebenlist
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-04       Impact factor: 11.205

9.  Biomarkers of subclinical inflammation and increases in glycaemia, insulin resistance and beta-cell function in non-diabetic individuals: the Whitehall II study.

Authors:  Christian Herder; Kristine Færch; Maren Carstensen-Kirberg; Gordon D Lowe; Rita Haapakoski; Daniel R Witte; Eric J Brunner; Michael Roden; Adam G Tabák; Mika Kivimäki; Dorte Vistisen
Journal:  Eur J Endocrinol       Date:  2016-08-04       Impact factor: 6.664

10.  Psoriasis and cardiometabolic traits: modest association but distinct genetic architectures.

Authors:  Manja Koch; Hansjörg Baurecht; Janina S Ried; Elke Rodriguez; Sabrina Schlesinger; Natalie Volks; Christian Gieger; Ina-Maria Rückert; Luise Heinrich; Christina Willenborg; Catherine Smith; Annette Peters; Barbara Thorand; Wolfgang Koenig; Claudia Lamina; Henning Jansen; Florian Kronenberg; Jochen Seissler; Joachim Thiery; Wolfgang Rathmann; Heribert Schunkert; Jeanette Erdmann; Jonathan Barker; Rajan P Nair; Lam C Tsoi; James T Elder; Ulrich Mrowietz; Michael Weichenthal; Sören Mucha; Stefan Schreiber; Andre Franke; Jochen Schmitt; Wolfgang Lieb; Stephan Weidinger
Journal:  J Invest Dermatol       Date:  2015-01-19       Impact factor: 8.551

View more
  17 in total

Review 1.  Autoimmunity and autoimmune co-morbidities in psoriasis.

Authors:  Kazuhisa Furue; Takamichi Ito; Gaku Tsuji; Takafumi Kadono; Takeshi Nakahara; Masutaka Furue
Journal:  Immunology       Date:  2018-02-06       Impact factor: 7.397

Review 2.  The IL-13-OVOL1-FLG axis in atopic dermatitis.

Authors:  Kazuhisa Furue; Takamichi Ito; Gaku Tsuji; Dugarmaa Ulzii; Yen Hai Vu; Makiko Kido-Nakahara; Takeshi Nakahara; Masutaka Furue
Journal:  Immunology       Date:  2019-10-01       Impact factor: 7.397

3.  Comorbidities and treatment patterns in adult patients with atopic dermatitis: results from a nationwide multicenter study.

Authors:  A Campanati; T Bianchelli; R Gesuita; C Foti; G Malara; G Micali; P Amerio; F Rongioletti; M Corazza; A Patrizi; K Peris; N Pimpinelli; A Parodi; M C Fargnoli; S P Cannavo; P Pigatto; G Pellacani; S M Ferrucci; G Argenziano; F Cusano; G Fabbrocini; L Stingeni; M C Potenza; M Romanelli; L Bianchi; A Offidani
Journal:  Arch Dermatol Res       Date:  2021-06-07       Impact factor: 3.033

Review 4.  The Roles of Vitamin C in Skin Health.

Authors:  Juliet M Pullar; Anitra C Carr; Margreet C M Vissers
Journal:  Nutrients       Date:  2017-08-12       Impact factor: 5.717

Review 5.  Psoriasis and Cardiovascular Comorbidities: Focusing on Severe Vascular Events, Cardiovascular Risk Factors and Implications for Treatment.

Authors:  Stephen Chu-Sung Hu; Cheng-Che E Lan
Journal:  Int J Mol Sci       Date:  2017-10-21       Impact factor: 5.923

6.  Atopic eczema and major cardiovascular outcomes: A systematic review and meta-analysis of population-based studies.

Authors:  Anna Ascott; Amy Mulick; Ashley M Yu; David Prieto-Merino; Morten Schmidt; Katrina Abuabara; Liam Smeeth; Amanda Roberts; Sinéad M Langan
Journal:  J Allergy Clin Immunol       Date:  2018-12-18       Impact factor: 10.793

Review 7.  The contribution of IL-17 to the development of autoimmunity in psoriasis.

Authors:  Masutaka Furue; Takafumi Kadono
Journal:  Innate Immun       Date:  2019-05-24       Impact factor: 2.680

Review 8.  Aryl Hydrocarbon Receptor in Atopic Dermatitis and Psoriasis.

Authors:  Masutaka Furue; Akiko Hashimoto-Hachiya; Gaku Tsuji
Journal:  Int J Mol Sci       Date:  2019-10-31       Impact factor: 5.923

Review 9.  Metabolic syndrome and the skin: a more than superficial association. Reviewing the association between skin diseases and metabolic syndrome and a clinical decision algorithm for high risk patients.

Authors:  Ellie C Stefanadi; Georgios Dimitrakakis; Christos-Konstantinos Antoniou; Dimitrios Challoumas; Nikita Punjabi; Inetzi Aggeliki Dimitrakaki; Sangeeta Punjabi; Christodoulos I Stefanadis
Journal:  Diabetol Metab Syndr       Date:  2018-02-21       Impact factor: 3.320

10.  Transcriptomic analysis of atopic dermatitis in African Americans is characterized by Th2/Th17-centered cutaneous immune activation.

Authors:  Shannon Wongvibulsin; Nishadh Sutaria; Suraj Kannan; Martin Prince Alphonse; Micah Belzberg; Kyle A Williams; Isabelle D Brown; Justin Choi; Youkyung Sophie Roh; Thomas Pritchard; Raveena Khanna; Amarachi C Eseonu; Jaroslaw Jedrych; Carly Dillen; Madan M Kwatra; Anna L Chien; Nathan Archer; Luis A Garza; Xinzhong Dong; Sewon Kang; Shawn G Kwatra
Journal:  Sci Rep       Date:  2021-05-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.